Regional Biocontainment Laboratories (Rbl) Construction Program

The summary for the Regional Biocontainment Laboratories (Rbl) Construction Program grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Regional Biocontainment Laboratories (Rbl) Construction Program: The National Institute of Allergy and Infectious Diseases (NIAID) invites applications for Construction Cooperative Agreement (UC6) funds to support the construction of new Regional Biocontainment Laboratories (RBLs) to be used for biomedical research and research training. Funds will be provided to program, design, construct, and commission comprehensive state-of-the-art laboratories that will support research on the NIAID Category A, B and C priority pathogens and emerging infectious diseases. At a minimum, the facility must include biosafety level-3 (BSL-3) and biosafety level-2 (BSL-2) biomedical research laboratories, a vivarium for small animals, and support space for research, administration, and building operations. The RBLs must preferentially support NIAID-funded biodefense and emerging infectious diseases research and will be members of the NIAID Biodefense Network. Additionally, the RBLs will serve as a regional resource for research institutions in the area, and must be available and prepared to assist national, state, and local public health efforts in the event of a bioterrorism emergency.
Federal Grant Title: Regional Biocontainment Laboratories (Rbl) Construction Program
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-04-032
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.389
CFDA Descriptions: Research Infrastructure
Current Application Deadline: No deadline provided
Original Application Deadline: Dec 29, 2004
Posted Date: Jul 06, 2004
Creation Date: Jul 06, 2004
Archive Date: Jan 28, 2005
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
Limited Competition: Competitive Revision for Technology Development within Biomedical Tec...
Centers of Biomedical Research Excellence (COBRE) (P20)
Instrument Development for Biomedical Applications (R21)
Limited Competition: Institutional Development Award (IDeA) Program Infrastructure for Cli...
High-End Instrumentation Grant Program (S10)
NCRR Science Education Partnership Award (SEPA) [R25]
Planning Grants for Institutional Clinical and Translational Science Awards
Institutional Clinical and Translational Science Award
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com